Deep TMS on alcoholics: Effects on cortisolemia and dopamine pathway modulation. A pilot study

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 4, 2015, Pages 283-290

  Ceccanti, Marco ^a   Inghilleri, Maurizio ^a   Attilia, Maria Luisa ^b   Raccah, Ruggero ^c   Fiore, Marco ^d   Zangen, Abraham ^e   Ceccanti, Mauro ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ATID Ltd Advanced Technology   (Italy)

^d EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Alcohol; Cortisol; Prefrontal cortex; Prolactin; Transcranic magnetic stimulation

Indexed keywords

ALCOHOL; DOPAMINE; HYDROCORTISONE; PROLACTIN; BIOLOGICAL MARKER;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLIC BEVERAGE; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DEEP TRANSCRANIAL MAGNETIC STIMULATION; DISEASE MARKER; DOUBLE BLIND PROCEDURE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NEUROMODULATION; PILOT STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME; ADVERSE EFFECTS; BINGE DRINKING; BLOOD; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC NERVE CELL; DRINKING BEHAVIOR; FOLLOW UP; HYPERPROLACTINEMIA; METABOLISM; MIDDLE AGED; NERVE CELL; PATIENT DROPOUTS; PREVENTION AND CONTROL;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; BINGE DRINKING; BIOMARKERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINERGIC NEURONS; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; NEURONS; PATIENT DROPOUTS; PILOT PROJECTS; PREFRONTAL CORTEX; PROLACTIN; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84953342394     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0188     Document Type: Article

References (51)

1. Amiaz, R., Levy, D., Vainiger, D., Grunhaus, L., and Zangen, A. 2009. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction, 104: 653–660. doi:10.1111/j.1360-0443.2008.02448.x. PMID:19183128.
2. Besemer, F., Pereira, A.M., and Smit, J.W. 2011. Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse. Neth. J. Med. 69: 318–323. PMID:21934176.
3. Chiu, S.K., Collier, C.P., Clark, A.F., and Wynn-Edwards, K.E. 2003. Salivary cortisol on Roche Elecsys Immunoassay system: pilot biological variation studies. Clin. Biochem. 36: 211–214. doi:10.1016/S0009-9120(02)00471-X. PMID: 12726930.
4. Damasio, A.R., Everitt, B.J., and Bishop, D. 1996. The somatic marker hypothesis and the possible functions of the prefrontal cortex [and Discussion]. Philos. Trans. R. Soc. B Biol. Sci. 351: 1413–1420. doi:10.1098/rstb.1996.0125.
5. De Timary, P., Cani, P.D., Duchemin, J., Neyrinck, A.M., Gihousse, D., Laterre, P.F., et al. 2012. The loss of metabolic control on alcohol drinking in heavy drinking alcohol-dependent subjects. PLoS ONE, 7: 38682. doi:10.1371/journal.pone.0038682.
6. Diorio, D., Viau, V., and Meaney, M.J. 1993. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic–pituitary–adrenal responses to stress. J. Neurosci. 1: 3839–3847. PMID:8396170.
7. Fahie-Wilson, M., Brunsden, P., Surrey, J., and Everitt, A. 2000. Macroprolactin and the Roche Elecsys Prolactin Assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clin. Chem. 46: 1993–1995. PMID:11106334.
8. Figueiredo, H.F., Bruestle, A., Bodie, B., Dolgas, C.M., and Herman, J.P. 2003. The medial prefrontal cortex differentially regulates stress-induced c-fos expression in the forebrain depending on type of stressor. Eur. J. Neurosci. 18: 2357–2364. doi:10.1046/j.1460-9568.2003.02932.x. PMID:14622198.
9. Funk, C.K., O’Dell, L.E., Crawford, E.F., and Koob, G.F. 2006. Corticotropinreleasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 26: 11324–11332. doi:10.1523/JNEUROSCI.3096-06.2006. PMID:17079660.
10. Garrido, P., De Blas, M., Ginè, E., Santos, A., and Mora, F. 2012. Aging impairs the control of prefrontal cortex on the release of corticosterone in response to stress and on memory consolidation. Neurobiol. Aging, 33: 827. PMID: 21794953.
11. Gibney, J., Smith, T.P., and McKenna, T.J. 2005. The impact on clinical practice of routine screening for macroprolactin. J. Clin. Endocrinol. Metab. 90: 3927–3932. doi:10.1210/jc.2004-2234. PMID:15811931.
12. Goldstein, R.Z., and Volkow, N.D. 2002. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry, 159: 1642–1652. PMID:12359667.
13. Hasin, D., Fenton, M.C., Skodol, A., Krueger, R., Keyes, K., Geier, T., et al. 2011. Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Arch. Gen. Psychiatry, 68: 1158–1167. PMID:22065531.
14. Isserles, M., Shalev, A.Y., Roth, Y., Peri, T., Kutz, I., Zlotnick, E., et al. 2013. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder — a pilot study. Brain Stimul. 6: 377–383. doi:10.1016/j.brs.2012.07.008. PMID:22921765.
15. Jentsch, J.D., and Taylor, J.R. 1999. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-relatedstimuli. Psychopharmacology(Berl.),146:373–390.doi:10.1007/PL00005483.
16. Kalivas, P.W., and O’Brien, C. 2008. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology, 33: 166–180. doi:10.1038/sj.npp.1301564. PMID:17805308.
17. Koob, G.F. 2008. A role for brain stress systems in addiction. Neuron, 59: 11–34. doi:10.1016/j.neuron.2008.06.012. PMID:18614026.
18. Koob, G.F., and Le Moal, M. 1997. Drug abuse: hedonic homeostatic dysregulation. Science, 278: 52–58. doi:10.1126/science.278.5335.52. PMID:9311926.
19. Koob, G.F., Kenneth Lloyd, G., and Mason, B.J. 2009. Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat. Rev. Drug Discov. 8: 500–515. doi:10.1038/nrd2828. PMID:19483710.
20. Lejoyeux, M., Solomon, J., and Adès, J. 1998. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol. 33: 563–575. doi:10.1093/alcalc/33.6.563. PMID:9872344.
21. Levkovitz, Y., Roth, Y., Harel, E.V., Braw, Y., Sheer, A., and Zangen, A. 2007. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol. 118: 2730–2744. doi:10.1016/j.clinph.2007.09.061. PMID:17977787.
22. Levkovitz, Y., Harel, E.V., Roth, Y., Braw, Y., Most, D., Katz, L.N., et al. 2009. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul. 2: 188–200. doi:10.1016/j.brs.2009.08.002. PMID:20633419.
23. Lewis, C.F. 2011. Substance use and violent behavior in women with antisocial personality disorder. Behav. Sci. Law, 29: 667–676. doi:10.1002/bsl.1006. PMID: 21928399.
24. Mantsch, J.R., Yuferov, V., Mathieu-Kia, A.-M., Ho, A., and Kreek, M.J. 2003. Neuroendocrine alterations in a high-dose, extended-access rat self-administration model of escalating cocaine use. Psychoneuroendocrinology, 28: 836–862. doi: 10.1016/S0306-4530(02)00088-4. PMID:12892653.
25. Melis, M., Spiga, S., and Diana, M. 2005. The dopamine hypothesis of drug addiction: hypodopaminergic state. Int. Rev. Neurobiol. 63: 101–154. doi:10.1016/S0074-7742(05)63005-X. PMID:15797467.
26. Merikangas, K.R., and McClair, V.L. 2012. Epidemiology of substance use disorders. Hum Genet. 131: 779–789. doi:10.1007/s00439-012-1168-0. PMID:22543841.
27. Modugno, N., Nakamura, Y., MacKinnon, C.D., Filipovic, S.R., Bestmann, S., Berardelli, A., et al. 2001. Motor cortex excitability following short trains of repetitive magnetic stimuli. Exp. Brain Res. 140: 453–459. doi:10.1007/s002210100843. PMID:11685398.
28. Nakamura, M. 2012. Therapeutic application of repetitive transcranial magnetic stimulation for major depression. Seishin Shinkeigaku Zasshi, 114: 1231–1249. PMID:23367835.
29. National Institute on Alcohol Abuse and Alcoholism. 1997. IXth Special Report to the US Congress on Alcohol and Health. US Department of Health and Human Services, National Institute on Alcohol and Abuse and Alcoholism. Rockville, Md.
30. Ozsoy, S., and Esel, E. 2008. Hypothalamic–pituitary–adrenal axis activity, dehydroepiandrosterone sulphate and their relationships with aggression in early and late alcohol withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry, 32: 340–347. PMID:17913324.
31. Radley, J.J., Arias, C.M., and Sawchenko, P.E. 2006. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J. Neurosci. 26: 12967–12976. doi:10.1523/JNEUROSCI.4297-06.2006. PMID:17167086.
32. Rando, K., Hong, K.I., Bhagwagar, Z., Li, C.S., Bergquist, K., Guarnaccia, J., et al. 2011. Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study. Am. J. Psychiatry, 168: 183–192. PMID:21078704.
33. Roberto, M., Cruz, M.T., Gilpin, N.W., Sabino, V., Schweitzer, P., Bajo, M., et al. 2010.Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol. Psychiatry, 67: 831–839. PMID:20060104.
34. Rosenberg, O., Shoenfeld, N., Zangen, A., Kotler, M., and Dannon, P.N. 2010.Deep TMS in a resistant major depressive disorder: a brief report. Depress. Anxiety, 27: 465–469. PMID:20455247.
35. Rossetti, Z.L., Hmaidan, Y., and Gessa, G.L. 1992. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 20: 221: 227–234. PMID: 1426002.
36. Rossi, S., Hallett, M., Rossini, P.M., and Pascual-Leone, A. 2009. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 120: 2008–2039. PMID:19833552.
37. Roth, Y., Amir, A., Levkovitz, Y., and Zangen, A. 2007. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J. Clin. Neurophysiol. 24: 31–38. doi:10.1097/WNP.0b013e31802fa393. PMID:17277575.
38. Sanchis-Segura, C., and Spanagel, R. 2006. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict. Biol. 11: 2–38. doi:10.1111/j.1369-1600.2006.00012.x. PMID:16759333.
39. Sinha, R., Fox, H.C., Hong, K.I., Hansen, J., Tuit, K., and Kreek, M.J. 2011. Effects of adrenal sensitivity, stress-and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch. Gen. Psychiatry, 68: 942–952. doi:10.1001/archgenpsychiatry.2011.49. PMID:21536969.
40. Sobel, L.C., and Sobel, M.B. 1992. Timeline followback: a technique for assessing self-reported alcohol consumption. In Measuring alcohol consumption: Psychosocial and biological methods. Edited by R.Z. Litten and J. Allen. Humana Press, New Jersey. pp. 41–72.
41. Solomon, R.L., and Corbit, J.D. 1974. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol. Rev. 81: 119–145. PMID:4817611.
42. Stahl, S.M. 2008 Essential psycopharmacology. 3rd ed. Cambridge University Press.
43. Tofts, P.S. 1990. The distribution of induced currents in magnetic stimulation of the nervous system. Phys. Med. Biol. 35: 1119–1128. doi:10.1088/0031-9155/35/8/008. PMID:2217537.
44. Tofts, P.S., and Branston, N.M. 1991. The measurement of electric field, and the influence of surface charge, in magnetic stimulation. Electroencephalogr. Clin. Neurophysiol. 81: 238–239. doi:10.1016/0168-5597(91)90077-B. PMID: 1710973.
45. Van den Wildenberg, E., Wiers, R.W., Dessers, J., Janssen, R.G., Lambrichs, E.H., Smeets, H.J., et al. 2007. A functional polymorphism of the µ-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcohol Clin. Exp. Res. 31: 1–10.doi:10.1111/j.1530-0277.2006.00258.x. PMID:17207095.
46. Wanat, M.J., Hopf, F.W., Stuber, G.D., Phillips, P.E., and Bonci, A. 2008. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J. Physiol. 586: 2157–2170. doi:10.1113/jphysiol.2007.150078. PMID:18308824.
47. Wilhelm, J., Heberlein, A., Karagülle, D., Gröschl, M., Kornhuber, J., Riera, R., et al. 2011. Prolactin serum levels during alcohol withdrawal are associated with the severity of alcohol dependence and withdrawal symptoms. Alcohol. Clin. Exp. Res. 35: 235–239. doi:10.1111/j.1530-0277.2010.01339.x. PMID: 21121933.
48. Zangen, A., Roth, Y., Voller, B., and Hallett, M. 2005. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin. Neurophysiol. 116: 775–779. doi:10.1016/j.clinph.2004.11.008. PMID:15792886.
49. Zhou, F.C., Anthony, B., Dunn, K.W., Lindquist, W.B., Xu, Z.C., and Deng, P. 2007. Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res. 1134: 148–161. doi:10.1016/j.brainres.2006.11.046. PMID:17198693.
50. Zhou, Y., Spangler, R., Ho, A., and Kreek, M.J. 2003a. Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic ‘binge’ cocaine. Brain Res. Mol. Brain Res. 114: 73–79. doi:10.1016/S0169-328X(03)00139-6. PMID: 12782395.
51. Zhou, Y., Spangler, R., Schlussman, S.D., Ho, A., and Kreek, M.J. 2003b. Alterations in hypothalamic–pituitary–adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic ‘binge’ cocaine and withdrawal. Brain Res. 964: 187–199. doi:10.1016/S0006-8993(02)03929-X. PMID:12576179.